Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across biomedical AI, cancer, cardiovascular diseases, immunity, age-related, rare and infectious diseases.

          Learn more

        • Biomedical AI
        • Cancer Innovations
        • Cardiovascular Research
        • Healthy Ageing
        • Infection & Immunity
        • Rare Diseases & Gene Therapy
        • Laboratories
        • Diseases
        • Impact
        • Technologies
        • Commercialisation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research.

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your will
        • Donate in memory
        • Get Involved
  • Careers & students
        • Careers & Students

          Postdoctoral and postgraduate students can work alongside world-leading medical researchers within state-of-the-art research facilities.

        • Careers
        • Study opportunities
  • Health hub
        • Health hub

          A range of practical information to assist in the possible preventions to disease through evidence-based research on how the body works.

          Learn more

        • Ageing
        • Exercise snack program
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events.

        • News
        • Statements
        • Events
        • Real stories
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges.

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
        • Animals in research
        • Contact
  • Donate
    Centenary Institute > News > Cardiovascular Initiative acknowledges Professor Semsarian AM

Cardiovascular Initiative acknowledges Professor Semsarian AM

Date time 25 November, 2022
News Type News type Research News
Professor Christopher Semsarian AM, Head of the Centenary Institute’s Agnes Ginges Centre for Molecular Cardiology has been recognised by the University of Sydney’s Cardiovascular Initiative (CVI) and been presented with an award for ‘Most Collaborative Cardiovascular Researcher’.

The award was one of several designed to acknowledge the achievements of CVI members as the Cardiovascular Initiative celebrated its five year anniversary with a policy workshop and networking event.

Professor Semsarian said he was extremely honoured to receive such an award from his peers.

“The Cardiovascular Initiative is all about bringing together researchers and practitioners from differing disciplines, to improve health outcomes for Australians in all areas of cardiovascular care,” said Professor Semsarian.

“The Initiative is extremely valuable. Working closely with so many fantastic experts has greatly benefited our team’s research into sudden cardiac death and ultimately improved outcomes for many patients and their families.”

Established by the University of Sydney, the Cardiovascular Initiative aims to improve cardiovascular health for current and future generations across Australia through connecting basic, clinical and translational research professionals.

Themes

  • Cardiovascular Research

    Cardiovascular Research

Research Fields

  • Genetic heart disease

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw

Phone number Phone Number +61 402 770 403

Email Email t.crawshaw@centenary.org.au

Recent Stories

  • Centenary Institute mourns the passing of Dame Marie Bashir

    The Centenary Institute is deeply saddened by the passing of our Founding Patron, Professor The Honourable Dame Marie Bashir AD CVO.
    News Type: Institute
    Date 21 Jan 2026
  • Funding boost for pioneering gene therapy and liver disease research

    Centenary Institute researchers have achieved success in the latest round of National Health and Medical Research Council (NHMRC) Ideas Grants, securing funding for innovative work in rare genetic diseases and liver disease.
    News Type: Media release
    Date 06 Jan 2026
  • A new era in therapeutic protein design

    A major new research project funded by the Australian Research Council (ARC) Discovery Projects scheme is commencing, with the Centenary Institute playing a central role. The project will establish an advanced platform to improve therapeutic protein design, supporting future developments in drugs, diagnostics and biotechnology.
    News Type: Research News
    Date 08 Dec 2025
  • Centenary researchers share insights at ageing conference

    Centenary Institute researchers played a prominent role at the Australian Biology of Ageing Conference 2025 this week, contributing new scientific insights on how Australians can live healthier lives as they age.
    News Type: Research News
    Date 20 Nov 2025

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About us
  • Governance
  • Corporate information

Research

  • Our researchers
  • News

Careers & studies

  • Career opportunities
  • Student opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement
  • Staff Intranet

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram